MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- SUN PHARMA - TEVA PHARMA (Israel)
SUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results
SUN PHARMA Change
Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 SUN PHARMA  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| SUN PHARMA Mar-19 |
TEVA PHARMA Dec-13 |
SUN PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 679 | 2,971 | - | |
| Low | Rs | 375 | 2,581 | - | |
| Sales per share (Unadj.) | Rs | 121.1 | 1,705.4 | - | |
| Earnings per share (Unadj.) | Rs | 13.4 | 106.5 | - | |
| Cash flow per share (Unadj.) | Rs | 20.7 | 244.4 | - | |
| Dividends per share (Unadj.) | Rs | 2.75 | 93.26 | - | |
| Dividend yield (eoy) | % | 0.5 | 3.4 | 15.5% | |
| Book value per share (Unadj.) | Rs | 172.6 | 1,894.3 | - | |
| Shares outstanding (eoy) | m | 2,399.26 | 848.00 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 4.4 | 1.6 | 267.3% | |
| Avg P/E ratio | x | 39.4 | 26.1 | 151.2% | |
| P/CF ratio (eoy) | x | 25.5 | 11.4 | 224.3% | |
| Price / Book Value ratio | x | 3.1 | 1.5 | 208.4% | |
| Dividend payout | % | 20.6 | 87.5 | 23.5% | |
| Avg Mkt Cap | Rs m | 1,264,650 | 2,354,396 | 53.7% | |
| No. of employees | `000 | 17.5 | 44.9 | 38.9% | |
| Total wages/salary | Rs m | 59,671 | 0 | - | |
| Avg. sales/employee | Rs Th | 16,608.1 | 32,176.1 | 51.6% | |
| Avg. wages/employee | Rs Th | 3,409.6 | 0 | - | |
| Avg. net profit/employee | Rs Th | 1,833.8 | 2,010.0 | 91.2% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 290,659 | 1,446,154 | 20.1% | |
| Other income | Rs m | 10,255 | 0 | - | |
| Total revenues | Rs m | 300,914 | 1,446,154 | 20.8% | |
| Gross profit | Rs m | 63,076 | 396,030 | 15.9% | |
| Depreciation | Rs m | 17,533 | 116,894 | 15.0% | |
| Interest | Rs m | 5,553 | 28,405 | 19.5% | |
| Profit before tax | Rs m | 50,246 | 250,731 | 20.0% | |
| Minority Interest | Rs m | 0 | 1,139 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | -12,144 | -164,591 | 7.4% | |
| Tax | Rs m | 6,009 | -3,061 | -196.3% | |
| Profit after tax | Rs m | 32,093 | 90,340 | 35.5% | |
| Gross profit margin | % | 21.7 | 27.4 | 79.2% | |
| Effective tax rate | % | 12.0 | -1.2 | -979.5% | |
| Net profit margin | % | 11.0 | 6.2 | 176.8% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 310,692 | 976,727 | 31.8% | |
| Current liabilities | Rs m | 173,396 | 851,788 | 20.4% | |
| Net working cap to sales | % | 47.2 | 8.6 | 546.8% | |
| Current ratio | x | 1.8 | 1.1 | 156.3% | |
| Inventory Days | Days | 99 | 91 | 109.1% | |
| Debtors Days | Days | 112 | 96 | 116.3% | |
| Net fixed assets | Rs m | 232,477 | 472,346 | 49.2% | |
| Share capital | Rs m | 2,399 | 3,560 | 67.4% | |
| Net worth | Rs m | 414,091 | 1,606,402 | 25.8% | |
| Long term debt | Rs m | 15,226 | 739,451 | 2.1% | |
| Total assets | Rs m | 646,938 | 3,304,925 | 19.6% | |
| Interest coverage | x | 10.0 | 9.8 | 102.3% | |
| Debt to equity ratio | x | 0 | 0.5 | 8.0% | |
| Sales to assets ratio | x | 0.4 | 0.4 | 102.7% | |
| Return on assets | % | 5.8 | 3.6 | 162.0% | |
| Return on equity | % | 7.8 | 5.6 | 137.8% | |
| Return on capital | % | 10.2 | 4.9 | 206.2% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 21,965 | 230,442 | 9.5% | |
| From Investments | Rs m | -6,813 | -81,655 | 8.3% | |
| From Financial Activity | Rs m | -27,305 | -276,431 | 9.9% | |
| Net Cashflow | Rs m | -8,442 | -127,644 | 6.6% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.19 Rs / USD
Compare SUN PHARMA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare SUN PHARMA With: VENUS REMEDIES PFIZER ABBOTT INDIA STERLING BIOTECH DR. DATSONS LABS
Today's Market
Sensex Ends 271 Points Higher; Capital Goods and Realty Stocks Rally(Closing)
Indian share markets witnessed buying interest during closing hours today and ended higher. Benchmark indices regained momentum amid huge buying seen in capital goods and realty stocks.
Related Views On News
SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)
Aug 14, 2019 | Updated on Aug 14, 2019For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)
Aug 6, 2019 | Updated on Aug 6, 2019Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)
May 30, 2019 | Updated on May 30, 2019For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)
Dec 20, 2018 | Updated on Dec 20, 2018Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsMost Popular
My Latest Stock Recommendation (Fast Profits Daily)
Jan 10, 2020The story behind my latest stock recommendation and an important announcement.
Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)
Jan 14, 2020The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.
Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)
Jan 15, 2020These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.
For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)
Jan 17, 2020This is how the biggest trading profits are made.
What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)
Jan 15, 2020If you're interested in the next Infosys, I'll tell you where to look.
More